doi: 10.1542/peds.2011-3865.
Epub 2012 Feb 27.
HPV vaccine recommendations
Collaborators
- PMID: 22371460
- DOI: 10.1542/peds.2011-3865
Item in Clipboard
HPV vaccine recommendations
Pediatrics.
2012 Mar.
Abstract
On October 25, 2011, the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention recommended that the quadrivalent human papillomavirus vaccine (Gardasil; Merck & Co, Inc, Whitehouse Station, NJ) be used routinely in males. The American Academy of Pediatrics has reviewed updated data provided by the Advisory Committee on Immunization Practices on vaccine efficacy, safety, and cost-effectiveness as well as programmatic considerations and supports this recommendation. This revised statement updates recommendations for human papillomavirus immunization of both males and females.
Similar articles
-
Recommendations on the use of quadrivalent human papillomavirus vaccine in males--Advisory Committee on Immunization Practices (ACIP), 2011.MMWR Morb Mortal Wkly Rep. 2011 Dec 23;60(50):1705-8. MMWR Morb Mortal Wkly Rep. 2011. PMID: 22189893
-
FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP).MMWR Morb Mortal Wkly Rep. 2010 May 28;59(20):630-2. MMWR Morb Mortal Wkly Rep. 2010. PMID: 20508594
-
FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP).MMWR Morb Mortal Wkly Rep. 2010 May 28;59(20):626-9. MMWR Morb Mortal Wkly Rep. 2010. PMID: 20508593
-
Update on universal childhood immunizations.Curr Opin Pediatr. 2008 Aug;20(4):483-9. doi: 10.1097/MOP.0b013e328306ebd1. Curr Opin Pediatr. 2008. PMID: 18622208 Review.
-
Country recommendations on the inclusion of HPV vaccines in national immunization programmes among high-income countries, June 2006-January 2008.Vaccine. 2008 Dec 2;26(51):6529-41. doi: 10.1016/j.vaccine.2008.08.067. Vaccine. 2008. PMID: 18805453 Review.
Cited by
-
Qualitative responses to a national physician survey on HPV vaccination.Vaccine. 2013 Apr 26;31(18):2267-72. doi: 10.1016/j.vaccine.2013.02.063. Epub 2013 Mar 13. Vaccine. 2013. PMID: 23499608 Free PMC article.
-
Providers' beliefs about the effectiveness of the HPV vaccine in preventing cancer and their recommended age groups for vaccination: Findings from a provider survey, 2012.Prev Med. 2015 Dec;81:405-11. doi: 10.1016/j.ypmed.2015.10.007. Epub 2015 Oct 24. Prev Med. 2015. PMID: 26598805 Free PMC article.
-
Improving Human Papillomavirus (HPV) Vaccination in the Postpartum Setting.J Community Health. 2017 Feb;42(1):66-71. doi: 10.1007/s10900-016-0230-6. J Community Health. 2017. PMID: 27476162 Free PMC article.
-
Managing uncertainty: healthcare professionals' meanings regarding the HPV vaccine.Int J Behav Med. 2014 Feb;21(1):29-36. doi: 10.1007/s12529-013-9343-9. Int J Behav Med. 2014. PMID: 24198036
-
Review of the clinical and biologic aspects of human papillomavirus-positive squamous cell carcinomas of the head and neck.Int J Radiat Oncol Biol Phys. 2014 Mar 15;88(4):761-70. doi: 10.1016/j.ijrobp.2013.08.029. Int J Radiat Oncol Biol Phys. 2014. PMID: 24606845 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
